RUNX1 and colon adenocarcinoma: In this study, we explored potential diagnostic and prognostic biomarkers in COAD through comprehensive bioinformatics analysis of TCGA data, and finally identified RUNX1 as a biomarker, and the overexpression of RUNX1 was detrimental to the prognosis and survival of COAD patients.